US 7662619
Sol-fusin: use of GP64-6His to catalyze membrane fusion
granted A61KA61K9/127
Quick answer
US patent 7662619 (Sol-fusin: use of GP64-6His to catalyze membrane fusion) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as Represented by the Secretary of the Department of Health and Human Services
- Grant date
- Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K9/127